Entrada Therapeutics Reports Third Quarter 2025 Financial Results
Go back to Entrada Therapeutics Reports Third Quarter 2025 Financial Results| (NASDAQ: TRDA) | Delayed: 7.78 +0.51 (7.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.27 | 52 Week High | $ | |||
| Open | $7.49 | 52 Week Low | $ | |||
| Day High | $7.79 | P/E | N/A | |||
| Day Low | $7.40 | EPS | $ | |||
| Volume | 241,824 | |||||

